Financhill
Back

Kimberly-Clark Vs. Mirum Pharmaceuticals Industry Stock Comparison

Sell
39

KMB
Kimberly-Clark

Last Price:
140.09
Seasonality Move:
3.27%
Sell
44

MIRM
Mirum Pharmaceuticals

Last Price:
39.35
Seasonality Move:
5.99%
Sell
39
Kimberly-Clark (KMB) is a Sell

Is Kimberly-Clark a Buy, Sell or Hold?

  • The current Kimberly-Clark [KMB] share price is $140.10. The Score for KMB is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KMB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Mirum Pharmaceuticals (MIRM) is a Sell

Is Mirum Pharmaceuticals a Buy, Sell or Hold?

  • The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KMB Stock Price Chart

What is Kimberly-Clark's stock price today?

  • The Kimberly-Clark share price today is $140.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KMB is experiencing selling pressure, which indicates risk of future bearish movement.

MIRM Stock Price Chart

What is Mirum Pharmaceuticals's stock price today?

  • The Mirum Pharmaceuticals share price today is $39.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.

KMB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -1292005 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (142.07 - 146.29) Sell
Bollinger Bands (100): (135.1 - 143.46) Buy

MIRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 44.04 Sell
Chaikin Money Flow: 27576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.13 - 42.69) Sell
Bollinger Bands (100): (27.3 - 41.42) Buy

KMB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.81 Sell
20-day SMA: 144.4 Sell
50-day SMA: 142.24 Sell
200-day SMA: 131.43 Buy
8-day EMA: 142.57 Sell
20-day EMA: 143.38 Sell
50-day EMA: 142.01 Sell
200-day EMA: 134.83 Buy

MIRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.48 Sell
20-day SMA: 41.45 Sell
50-day SMA: 40.72 Sell
200-day SMA: 31.06 Buy
8-day EMA: 40.12 Sell
20-day EMA: 40.8 Sell
50-day EMA: 39.41 Sell
200-day EMA: 32.87 Buy

Kimberly-Clark Earnings Growth & KMB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.14 per share, an increase this year of $0.69 per share, and an increase next year of $0.35 per share.

Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.

Kimberly-Clark Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Mirum Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):